
Dasatib 50mg Tablet
Marketer
Samarth Life Sciences Pvt Ltd
Salt Composition
Dasatinib (50mg)
Overview Dasatib 50mg Tablet
Dasatinib 50mg tablets treat chronic myeloid leukemia (a type of blood cancer). This medication is prescribed for patients whose leukemia hasn't responded to other treatments or who can't tolerate them due to adverse reactions. Dasatinib 50mg tablets may be taken with or without food, but consistent daily timing maximizes effectiveness. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be noticeable for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) are possible; consult your doctor immediately if these occur. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of taking this medication. Dasatinib can lower blood cell counts, increasing infection risk; regular blood tests are essential. Inform your healthcare provider about all other medications you're taking, as interactions are possible. This medicine is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Primary Ingredients of Dasatib 50mg Tablet
No information provided. Unable to rephrase.
Uses of Dasatib 50mg Tablet
Chronic myelogenous leukemia, a type of blood cancer
Major Benefits of Dasatib 50mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the 50mg Dasatib tablet whole; do not break, crush, or chew it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Dasatib 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dasatib 50mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 50mg Dasatib tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How Dasatib 50mg Tablet works:
Dasatinib 50mg tablets are prescribed for cancer treatment. Their mechanism involves inhibiting a faulty protein responsible for stimulating cancerous cell proliferation, thereby hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dasatib 50mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Dasatinib 50mg tablets is contraindicated during pregnancy due to confirmed harm to the fetus. In exceptional life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the risks. Physician consultation is advised.
Breast feedingUNSAFE
Breastfeeding is contraindicated while taking Dasatinib 50mg tablets due to the potential for infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Dasatib 50mg Tablet side effects. Exercise caution while driving if dizziness or blurred vision occur after taking Dasatib 50mg Tablet.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can likely safely take Dasatib 50mg tablets. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely take Dasatinib 50mg tablets without requiring a dosage alteration.
What if you forget to take Dasatib 50mg Tablet :
Omit any missed Dasatib 50mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Dasatib 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
